FolkKB

Burnet Bloodwort

Sanguisorba officinalis

Sanguisorba officinalis，又称血艾草或普通烧草，在欧洲和亚洲的传统医学实践中起源。它传统上用于治疗烧伤、伤口和皮肤状况等多种用途，但具体用途因不同文化而异。科学证据表明，S. officinalis 含有生物活性化合物，具有潜在的好处，包括抑制黑色素生成并促进通过 ERα 依赖信号通路的巨核细胞分化。此外，该植物提取物显示出缓解化疗引起的中性粒细胞减少症的潜力，通过增强中性粒细胞分化和功能恢复来实现。关于安全性，迄今为止没有报告过显著的不良反应或主要问题。目前没有证据表明 Sanguisorba officinalis 与药物之间存在相互作用，但进一步的研究对于完全了解其潜在应用及其机制至关重要。

速览
最佳证据
D
注意事项
—

仅供参考。传统用法并不代表已被证实有效。证据与安全性各不相同，请查阅所引来源。

科学怎么说

  • 研究从宋梅草根中鉴定出十二个新的倍半萜类化合物，其中一些显示出对黑色素生成的显著抑制活性。 D PMID
  • Sanguisorba officinalis L. 单体表没食子儿茶素通过ERα依赖的SRC/PI3K/AKT信号通路促进体内外巨核细胞分化，且无毒性。 D PMID
  • 来自沙苑子的二号紫草苷通过调节SPI1和C/EBPϵ促进中性粒细胞分化和功能恢复，减轻化疗引起的中性粒细胞减少症。 D PMID
  • Kytococcus，尤其是 K. schroeteri 和 S. hominis，与足部异味有关，而 Sanguisorba officinalis 和 Eucalyptus globulus 的提取物可以抑制异丁酸的产生。 D PMID

Frequently asked questions

What is Burnet Bloodwort?

Burnet Bloodwort (Sanguisorba officinalis) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.

What does the scientific evidence say about Burnet Bloodwort?

4 sourced findings are recorded for Burnet Bloodwort; the strongest carries evidence grade D. For example: 研究从宋梅草根中鉴定出十二个新的倍半萜类化合物，其中一些显示出对黑色素生成的显著抑制活性。

How strong is the evidence for Burnet Bloodwort?

The strongest finding for Burnet Bloodwort carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).

Is Burnet Bloodwort safe? What are the side effects?

No major safety issues are recorded for Burnet Bloodwort in our sources, but the data may be incomplete. Consult a qualified professional before use.

Does Burnet Bloodwort interact with medications?

No drug interactions are recorded for Burnet Bloodwort in our sources. This does not rule them out — check with a pharmacist.

What are the common names of Burnet Bloodwort?

Burnet Bloodwort is also known as: Кровохлёбка лекарственная, Grande pimprenelle.

Is Burnet Bloodwort a proven treatment?

No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.

来源

  1. T2 Ziyuglycoside II ameliorates chemotherapy-induced neutropenia by promoting neutrophil differentiation and functional recovery via SPI1 and C/EBPϵ transcriptional regulation. literature abstract metadata
  2. T2 Epigallocatechin promotes megakaryocyte differentiation via ERα-dependent SRC/PI3K/AKT signaling for thrombocytopenia treatment. literature abstract metadata
  3. T2 New patchoulol- and guaiane-type sesquiterpenoids from Sanguisorba officinalis with anti-melanogenic activity. literature abstract metadata
  4. T2 Kytococcal and staphylococcal strains isolated from Japanese subjects with foot malodor and their control. literature abstract metadata